1. Home
  2. CABA vs CCRN Comparison

CABA vs CCRN Comparison

Compare CABA & CCRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cabaletta Bio Inc.

CABA

Cabaletta Bio Inc.

HOLD

Current Price

$2.94

Market Cap

319.6M

Sector

Health Care

ML Signal

HOLD

Logo Cross Country Healthcare Inc. $0.0001 Par Value

CCRN

Cross Country Healthcare Inc. $0.0001 Par Value

HOLD

Current Price

$8.84

Market Cap

270.9M

ML Signal

HOLD

Company Overview

Basic Information
Metric
CABA
CCRN
Founded
2017
1986
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Professional Services
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
319.6M
270.9M
IPO Year
2019
2001

Fundamental Metrics

Financial Performance
Metric
CABA
CCRN
Price
$2.94
$8.84
Analyst Decision
Strong Buy
Buy
Analyst Count
7
4
Target Price
$14.57
$13.15
AVG Volume (30 Days)
2.3M
555.2K
Earning Date
03-16-2026
03-04-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$816,484,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$4.35
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.99
$7.43
52 Week High
$3.78
$15.30

Technical Indicators

Market Signals
Indicator
CABA
CCRN
Relative Strength Index (RSI) 46.38 44.49
Support Level $2.11 $7.68
Resistance Level $3.34 $9.40
Average True Range (ATR) 0.21 0.46
MACD -0.06 -0.06
Stochastic Oscillator 18.33 16.18

Price Performance

Historical Comparison
CABA
CCRN

About CABA Cabaletta Bio Inc.

Cabaletta Bio Inc is a clinical-stage biotechnology company focused on the discovery and development of engineered T cell therapies and exploring their potential to provide a deep and durable, perhaps curative, treatment for patients with B cell-mediated autoimmune diseases. Its proprietary technology utilizes Chimeric AutoAntibody Receptor, or CAART cells, that are designed to selectively bind and eliminate only specific B cells that produce disease-causing autoantibodies, or pathogenic B cells, while sparing normal B cells. Its CABA platform encompasses two strategies: CARTA (chimeric antigen receptor T cells for autoimmunity) and CAART (chimeric autoantibody T cells) that have the potential to be applied across a broad range of autoimmune diseases.

About CCRN Cross Country Healthcare Inc. $0.0001 Par Value

Cross Country Healthcare Inc is a provider of total talent management services, including strategic workforce solutions, contingent staffing, permanent placement and consultative services for healthcare customers. The company operates in two business segments: the nurse and allied staffing segment, which generates a vast majority of revenue, offers temporary and permanent placements of travel and local nurses and allied professionals, and other outsourcing services.: the Physician Staffing segment provides licensed practitioners across a broad array of specialties, as well as certified registered nurse anesthetists (CRNAs), nurse practitioners (NPs), and physician assistants (PAs) on temporary assignments. The company earns majority of its revenue from the United States.

Share on Social Networks: